Harrow Q2 Miss Deepens Losses, Validating Bearish Stance

What happened

Harrow reported a wider-than-expected Q2 loss of $0.34 per share, missing the Zacks consensus estimate of -$0.23 and reversing a $0.24 profit a year ago. The revenue miss confirms that top-line momentum may be stalling, despite prior strong growth in brands like IHEEZO and VEVYE. This extends a pattern of volatile profitability, as the company remains burdened by high interest costs on its $250M 8.625% notes and a net debt/EBITDA of 8.2x. The miss aligns with the DeepValue master report’s SELL thesis, which highlighted execution risk and an equity valuation that embeds overly optimistic assumptions. With free cash flow still unreliable and regulatory overhang, the Q2 report erodes confidence in a near-term earnings inflection.

Implication

The wider loss and revenue shortfall suggest that Harrow’s branded growth may not be sufficient to overcome its structural cost burden, making a return to sustained positive earnings unlikely in the next few quarters. The stock’s rich valuation on price-to-book (29x) and absent P/E support leaves it vulnerable to further re-rating if operating momentum continues to disappoint. The 8.625% coupon on $250M debt consumes a significant portion of cash flow, leaving little room for error; any regulatory setback at the NJ facility could tip the balance sheet into distress. While the recent refinancing eased immediate liquidity fears, the Q2 miss indicates that organic cash generation remains insufficient to comfortably service debt. Prudent investors should avoid the name or maintain a short position until there is clear evidence of durable free cash flow and meaningful deleveraging.

Thesis delta

The Q2 2026 miss reinforces the existing SELL thesis announced in the master report. With losses deepening and revenue missing estimates, the equity’s risk/reward skews further to the downside, and the assumptions underpinning the bullish case appear increasingly strained. No shift in stance is warranted—the sell recommendation stands with heightened urgency.